The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome
Open accessAbstract
Background— Postural tachycardia syndrome (POTS) induces disabling chronic orthostatic intolerance notable for an excessive increase in heart rate that occurs on standing. Many current therapeutic strategies focus on sympatholysis, but the alternative strategy of enhancing cardiovagal tone has not been studied. The objective of this study was to test the hypothesis that acetylcholinesterase inhibitors will attenuate the tachycardia and improve symptom burden in patients with POTS. Methods and Results— Seventeen patients with POTS underwent acute drug trials of pyridostigmine 30 mg orally and placebo, on separate mornings, in a randomized crossover design. Blood pressures, heart rate, and symptoms were assessed while patients were seated and after they had been standing for up to 10 minutes both before the study drug was given and at 2 and 4 hours after study drug. The heart rate was significantly lower at 2 hours after pyridostigmine than after placebo (100±16 versus 111±14 bpm, P =0.001). Pyridostigmine significantly decreased the standing heart rate from baseline (119±16 bpm) at 2 hours (104±16 bpm, P <0.001) and 4 hours (100±16 bpm, P <0.001) after administration. There was no significant change in blood pressure. The decrease in symptom burden within 4 hours after study drug was significantly greater with pyridostigmine than placebo (−10.4±14.0 AU versus 0.6±7.5 AU, P <0.025). Conclusions— Acute acetylcholinesterase inhibition significantly attenuated tachycardia in POTS. There was also an improvement in symptom burden with this promising therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The drug blunts orthostatic tachycardia and can improve chronic symptoms but is limited by adverse effects such as diarrhea, abdominal pain and cramps, nausea, and increased urinary urgency and frequency.45,46”
From 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope (2015) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A 2005 study found that pyridostigmine (30–60 mg, given orally 3 times daily) can acutely decrease upright heart rate in patients with POTS;48”
From Diagnosis and management of postural orthostatic tachycardia syndrome (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three of these experimental proof-of-concept trials, of Desmopressin, Pyridostigmine, and Propranolol (low dose more than high dose and high dose more than placebo) were effective in reducing symptom burden compared to placebo or high dose controls after 4 h tilt test.”
From Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies (2023) · cites this paper as Raj et al., 2005
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This symptom score has been previously used by our center 6 and the symptoms were chosen as they reflect common complaints of patients with POTS.”
From Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More (2009) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Many patients with POTS have increased sympathetic nervous system tone measured with direct nerve recordings 5 or biochemically with an elevated plasma norepinephrine on standing 6–8.”
From Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More (2009) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Pyridostigmine (a cholinergic agonist that works by inhibiting acetylcholinesterase) 30 to 60 mg 3 times a day can increase parasympathetic autonomic tone (107,108) and has a lower risk of hypertension compared with other medications.”
From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [107]
In the citing paper
“Increasing parasympathetic tone with pyridostigmine can also curtail HR in POTS [65] (HRS Class IIb) [8].”
From Postural tachycardia syndrome: beyond orthostatic intolerance (2015) · cites this paper as [65]
In the citing paper
“Supine and upright blood pressures were no different between the group that received pyridostigmine and the placebo group.”
From Postural orthostatic tachycardia syndrome: mechanisms and new therapies (2020) · cites this paper as [80]
In the citing paper
“In a study of 17 POTS patients, symptoms and standing heart rate were significantly reduced after pyridostigmine administration versus placebo in the acute setting (80).”
From Postural orthostatic tachycardia syndrome: mechanisms and new therapies (2020) · cites this paper as [80]
In the citing paper
“Acetylcholinesterase inhibitor.”
From Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management (2019) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O’Malley, K. J., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,262
A CONTROLLED TRIAL OF ARTHROSCOPIC SURGERY FOR OSTEOARTHRITIS OF THE KNEE
Ruce, J. B., Imberly, K., Etersen, A. J. P., Enke, T. E. J. M., Rody, A., Uykendall, D. A. H. K., Ohn, J., Shton, C. A. M. A., & Ray, E. P. W. (2002) · Cited by 1,087
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Deconstructing the Placebo Effect and Finding the Meaning Response
Moerman, D. E., & Jonas, W. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00011 · Cited by 745
Connolly, S. J., Sheldon, R., Thorpe, K. E., Roberts, R. S., Ellenbogen, K. A., Wilkoff, B. L., Morillo, C., Gent, M., & for the VPS II Investigators (2003) · JAMA · doi:10.1001/jama.289.17.2224 · Cited by 500
The neuropathic postural tachycardia syndrome
Jacob, G., Costa, F., Shannon, J. R., Robertson, R. M., Wathen, M., Stein, M., Biaggioni, I., Ertl, A., Black, B., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431404 · Cited by 398
Self-citationBeecher, H. K. (1961) · JAMA · doi:10.1001/jama.1961.63040260007008 · Cited by 318
Postural tachycardia syndrome (POTS)
Lamotte, G., & Low, P. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85492-4.00118-6 · Cited by 301
Raj, S. R., Biaggioni, I., Yamhure, P. C., Black, B. K., Paranjape, S. Y., Byrne, D. W., & Robertson, D. (2005) · Circulation · doi:10.1161/01.cir.0000160356.97313.5d · Cited by 286
Self-citationPlacebos and placebo effects in medicine: historical overview
de Craen, A. J. M., Kaptchuk, T. J., Tijssen, J. G. P., & Kleijnen, J. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909201005 · Cited by 219
Quality of Life in Patients With Postural Tachycardia Syndrome
Benrud-Larson, L. M., Dewar, M. S., Sandroni, P., Rummans, T. A., Haythornthwaite, J. A., & Low, P. A. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.6.531 · Cited by 217
Singer, W. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1294 · Cited by 196
Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system
Jacob, G., Robertson, D., Mosqueda-Garcia, R., Ertl, A. C., Robertson, R. M., & Biaggioni, I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00133-2 · Cited by 164
Self-citationBerrouschot, J., Baumann, I., Kalischewski, P., Sterker, M., & Schneider, D. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00027 · Cited by 152
Idiopathic Orthostatic Intolerance and Postural Tachycardia Syndromes
Jacob, G., & Biaggioni, I. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199902000-00003 · Cited by 136
Self-citationThe Postural Orthostatic Tachycardia Syndrome:
Kanjwal, Y., KOSINSKI, D. J., & Grubb, B. P. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.t01-1-00262.x · Cited by 103
Freitas, J., Santos, R., Azevedo, E., Costa, O., Carvalho, M., & Falcão de Freitas, A. (2000) · Clinical Autonomic Research · doi:10.1007/bf02281112 · Cited by 78
Stewart, J. M., Munoz, J., & Weldon, A. (2002) · Circulation · doi:10.1161/01.cir.0000040999.00692.f3 · Cited by 71
Gaffney, F. A. (1983) · CHEST Journal · doi:10.1378/chest.83.2_supplement.436 · Cited by 43
Joaquim, L. F., Farah, V., Bernátová, I., Fazan, R., Grubbs, R. D., & Morris, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01136.2003 · Cited by 38
Gaffney, F. A., Lane, L. B., Pettinger, W., & Blomqvist, C. G. (1983) · Chest · doi:10.1378/chest.83.2.436 · Cited by 36
Reversal of orphenadrine-induced ventricular tachycardia with physostigmine
Danze, L. K., & Lanqdorf, M. I. (1991) · Journal of Emergency Medicine · doi:10.1016/0736-4679(91)90217-4 · Cited by 23
Antiphospholipid antibodies. A marker of lupus carditis?
O’Rourke, R. A. (1990) · Circulation · doi:10.1161/01.cir.82.2.636 · Cited by 20
Role of pacemakers in treating neurocardiogenic syncope
Raj, S. R., & Sheldon, R. S. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200301000-00007 · Cited by 7
Self-citation
Research works printed but not linked: 1
- Singer W, Hines SM, Opfer-Gehrking TL, Low PA. Influence of acetylcholinesterase inhibition on baroreflex sensitivity in patients with orthostatic intolerance. Neurology. 2004; 62: A420.Abstract.
Cited by
Sorted by citations
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,312
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
“The drug blunts orthostatic tachycardia and can improve chronic symptoms but is limited by adverse effects such as diarrhea, abdominal pain and cramps, nausea, and increased urinary urgency and frequency.(45,46) Central sympatholytic agents can be useful in patients with the central hyperadrenergic form of POTS but mi…”
BackgroundSelf-citationPostural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370
Postural tachycardia syndrome (POTS)
LOW, P. A., SANDRONI, P., JOYNER, M., & SHEN, W. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01407.x · Cited by 358
Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management
Fedorowski, A. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12852 · Cited by 352
Metadata
- Authors
- Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D.
- Affiliations
- Vanderbilt University (US)
- Venue
- Circulation
- Published
- 2005-05-31
- Volume
- 111
- Issue
- 21
- Pages
- 2734-2740
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2119590578
- Semantic Scholar
- ea9f143f5988a05a320e77ea7e1b2ae553870d10
- Cited by
- 171
- References
- 25
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 12 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 11 · 2013: 13 · 2012: 10
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vanderbilt University (M01 RR00095)
- Deutsches Krebsforschungszentrum
- National Institutes of Health
- National Heart, Lung, and Blood Institute (2P01-HL-56693, P01HL056693)
- National Center for Research Resources (M01RR000095, M01-RR-00095, K23RR020783)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Keywords
- postural orthostatic tachycardia syndrome, acetylcholinesterase inhibitors, pyridostigmine, orthostatic intolerance, heart rate, symptom burden, drug trials
- MeSH terms
- Adult, Blood Pressure, Cholinesterase Inhibitors, Female, Heart Rate, Humans, Male, Middle Aged, Posture, Pyridostigmine Bromide, Tachycardia, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
